Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06424197 · ClinicalTrials.gov registry record · NA
Colorectal Cancer Screening Intervention Study
A NA study, sponsored by Oakland University.
- Completed
- Registry status
- NA
- Development phase
- 799
- Enrollment target
NCT06424197: Completed NA study, sponsored by Oakland University.
NCT06424197 is a NA study that has completed, run by Oakland University. The registered enrollment target is 799 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06424197, a NA study, has completed, sponsored by Oakland University.
- COMPLETED
- Registry status
- NA
- Development phase
- 799 participants
- Enrollment target
Study Summary
Colorectal cancer (CRC) is one of the leading causes of cancer mortality in the United States, and African Americans (AfAms) still fare worse in CRC incidence and mortality compared to European Americans (EuAms). We propose to examine whether combining both fear-reduction and racially-targeted norm-based messages will increase at-home stool-based CRC screening receptivity and uptake for all African American regardless of level of racial identity. Given low return rates of at-home screening kits, we will also explore whether making an explicit commitment to return screening kits is associated with increased kit returns.
Primary Outcome
FIT Kit request
Interventions
- OTHER Racial group-targeted messages
- OTHER Explicit Commitment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 799 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
What the finished NCT06424197 record still lists
NCT06424197 is an interventional study that assigns participants to a tested intervention. The registered 799 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 2 interventions - of which Racial group-targeted messages is the first listed.
NCT06424197 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06424197 about?
NCT06424197 is a clinical study titled "Colorectal Cancer Screening Intervention Study". Colorectal cancer (CRC) is one of the leading causes of cancer mortality in the United States, and African Americans (AfAms) still fare worse in CRC incidence and mortality compared to European Americans (EuAms). We propose to examine whether combining both fear-reduction and racially-targeted norm-...
What is the current status of trial NCT06424197?
This trial is currently completed. It is a NA study. The enrollment target is 799 participants. The study started on 2023-03-01. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT06424197?
The interventions under investigation include: Racial group-targeted messages (OTHER), Explicit Commitment (OTHER).
Who is sponsoring clinical trial NCT06424197?
This trial is sponsored by Oakland University, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06424197's enrollment target sits among peer trials
799 140th of 2000 higher than 1,861 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI